Purple Biotech (PPBT) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Purple Biotech has announced a $2.8 million registered direct offering of American Depositary Shares, with H.C. Wainwright & Co. serving as the exclusive placement agent. The funds will support the company’s oncology therapeutic candidates and general corporate needs. The offering is expected to close around December 4, 2024, pending customary conditions.
For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.
